The Altix UV massively parallel supers might not be shipping until the third quarter of this year, but Silicon Graphics is lining up customers who want to get the box early. The latest customer to ink a deal for an Altix UV is the United Kingdom's Institute of Cancer Research.
Because Intel has yet to launch the "Beckton" eight-core Nehalem-EX processors that are the compute engines in the Altix UV machines, the details are a bit sketchy on exactly what ICR is buying, and the organization did not divulge what systems it currently has in place in Reading, where ICR does research and simulations to come up with new treatments for a variety of cancers.
ICR was founded in 1909 and is a college in the University of London. It is partnered with the Royal Marsden NHS Foundation Trust. According to ICR's 2009-2015 strategic planning report, the researchers laboring at the facility were the first to figure out that DNA damage causes cancer and figured out the link between smoking and lung cancer. ICR has drilled down deeper into the cell genetics to find out what genes are associated with which cancers, leading to earlier detection, and it has synthesized chemotherapy drugs and tweaked radiotherapy techniques so they are less toxic and more effective.
Read Full Article Here:
http://www.theregister.co.uk/2010/01/29/sgi_altix_uv_icr/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment